Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · Real-Time Price · USD
2.040
-0.040 (-1.92%)
At close: Dec 12, 2024, 4:00 PM
2.030
-0.010 (-0.49%)
After-hours: Dec 12, 2024, 7:07 PM EST
-1.92%
Market Cap 256.15M
Revenue (ttm) n/a
Net Income (ttm) -70.21M
Shares Out 125.56M
EPS (ttm) -0.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 91,330
Open 2.110
Previous Close 2.080
Day's Range 2.020 - 2.125
52-Week Range 1.875 - 3.455
Beta 0.97
Analysts Hold
Price Target 3.58 (+75.49%)
Earnings Date Oct 29, 2024

About NAUT

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affin... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 167
Stock Exchange NASDAQ
Ticker Symbol NAUT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for NAUT stock is "Hold." The 12-month stock price forecast is $3.58, which is an increase of 75.49% from the latest price.

Price Target
$3.58
(75.49% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research's esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging Dr. Mal...

6 weeks ago - GlobeNewsWire

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company wil...

6 weeks ago - GlobeNewsWire

Nautilus Biotechnology, Inc. (NAUT) Q3 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Conference Call October 29, 2024 8:30 AM ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder and Chief Executiv...

6 weeks ago - Seeking Alpha

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Conference Call July 30, 2024 8:30 AM ET Company Participants Ji-Yon Yi - Investor Relations Sujal Patel - Co-Founder & Chief Executive Off...

4 months ago - Seeking Alpha

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial resul...

4 months ago - GlobeNewsWire

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report ...

5 months ago - GlobeNewsWire

Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Conference Call April 30, 2024 8:30 AM ET Company Participants Sujal Patel - Co-Founder & Chief Executive Officer Parag Mallick - Co-Founde...

8 months ago - Seeking Alpha

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial resu...

8 months ago - GlobeNewsWire

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report...

8 months ago - GlobeNewsWire

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial resul...

10 months ago - GlobeNewsWire

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company wil...

10 months ago - GlobeNewsWire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report ...

11 months ago - GlobeNewsWire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Society award recognizes Dr. Mallick's decades of innovative leadership and science advancing the field of computational proteomics Society award recognizes Dr. Mallick's decades of innovative leaders...

1 year ago - GlobeNewsWire

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome Former Quantapore founder...

1 year ago - GlobeNewsWire

Nautilus Biotechnology, Inc. (NAUT) Q3 2023 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET Company Participants Carrie Mendivil - IR Sujal Patel - Co-Founder & CEO Parag Mallick - Co-Fou...

1 year ago - Seeking Alpha

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial resul...

1 year ago - GlobeNewsWire

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report ...

1 year ago - GlobeNewsWire

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company wil...

1 year ago - GlobeNewsWire

Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Call Transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executi...

1 year ago - Seeking Alpha

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financia...

1 year ago - GlobeNewsWire

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report ...

1 year ago - GlobeNewsWire

Nautilus Biotechnology to Participate in Upcoming June Investor Conferences

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will...

1 year ago - GlobeNewsWire

Nautilus Biotechnology Reports First Quarter 2023 Financial Results

SEATTLE, May 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial result...

1 year ago - GlobeNewsWire

Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023

SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report...

1 year ago - GlobeNewsWire